1376.7000 40.00 (2.99%)
NSE Aug 12, 2025 15:31 PM
Volume: 377.0K
 

1376.70
2.99%
Phillip Capital
any volume of Artemisininbased Combination Therapy (ACTs) to IPCA, considering the continuingUSFDAimportbanonIPCA'splants.Wehadbuiltascenarioofnormalcyinthis supply,startingQ1FY17.Withnoorderallocation,IPCAwouldseeadverserevenueimpact...
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended